Fresenius Medical Cuts 2026 Profit Outlook
Fresenius Medical Care lowered its 2026 operating income outlook after US treatment volumes dropped for a third consecutive quarter. The German dialysis specialist reported lower quarterly earnings amid regulatory and inflation headwinds.
Xurve View
Insights:
Xurve View
Fresenius Medical Care AG cut the upper end of its 2026 operating income forecast after treatment volumes in the United States dropped 1.1% during the third quarter. The Germany-based dialysis provider now expects full-year operating income to range from flat to a mid-single-digit percentage decline. Investors are closely monitoring the North American market as CEO Shervin J. Korangy works to return the company's largest revenue source to growth.
